A Pilot Study of Oxaloacetate in Subjects With Treated PD
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if Oxaloacetate (OAA) is a safe and effective
treatment for Parkinson's disease. Each subject will be asked to make 3 study visits and
complete two safety follow-up phone calls over a 4 month period.